The name CERN comes from the French phrase Conseil Européen pour la Recherche Nucléaire (European Council for Nuclear Research), a provisional organization formed in 1952. Known worldwide for groundbreaking research in physics.
A portable photon-counting CT scanner built using CERN’s Medipix3 detector technology has received FDA clearance, opening the door for wider clinical use.
Medipix technology is based on hybrid pixel detectors originally designed at CERN to detect particles in high-energy physics experiments. Scientists later realized that the same precision could dramatically improve medical imaging.
So, what makes photon-counting CT different from conventional CT scans?
Traditional CT systems collect X-ray signals and combine them to create a 3D image. Photon-counting CT, however, detects and measures individual X-ray photons along with their energy levels. This allows the scanner to generate sharper, more detailed, and highly precise three-dimensional images.
The benefits are remarkable:
- Better visualization of tissues and tiny structures
- Improved differentiation between materials and abnormalities
- Greater diagnostic accuracy for clinicians
- Potentially lower radiation exposure in some applications
This technology could significantly improve the early detection and evaluation of diseases involving the heart, lungs, bones, and even cancer.
What began as a tool for exploring the mysteries of the universe is now becoming a powerful instrument for saving lives.
MBH/PS